| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 50 | 2025 | 875 | 4.610 |
Why?
|
| Heart Failure | 29 | 2023 | 2398 | 1.820 |
Why?
|
| Graft Rejection | 18 | 2025 | 559 | 1.720 |
Why?
|
| Heart-Assist Devices | 22 | 2022 | 1085 | 1.600 |
Why?
|
| Graft Survival | 9 | 2025 | 473 | 0.880 |
Why?
|
| Natriuretic Peptide, Brain | 6 | 2009 | 342 | 0.860 |
Why?
|
| Cardiomyopathies | 11 | 2022 | 509 | 0.830 |
Why?
|
| Ventricular Dysfunction, Left | 9 | 2017 | 375 | 0.760 |
Why?
|
| Child | 79 | 2025 | 25758 | 0.700 |
Why?
|
| Kidney Transplantation | 2 | 2021 | 571 | 0.660 |
Why?
|
| Child, Preschool | 57 | 2025 | 14719 | 0.660 |
Why?
|
| Retrospective Studies | 54 | 2023 | 17367 | 0.580 |
Why?
|
| Adolescent | 60 | 2025 | 20530 | 0.560 |
Why?
|
| Cardiomyopathy, Dilated | 8 | 2022 | 215 | 0.540 |
Why?
|
| Infant | 44 | 2025 | 13037 | 0.530 |
Why?
|
| Postoperative Complications | 12 | 2025 | 3129 | 0.490 |
Why?
|
| Death, Sudden, Cardiac | 6 | 2020 | 274 | 0.480 |
Why?
|
| Cardiomyopathy, Hypertrophic | 6 | 2016 | 158 | 0.460 |
Why?
|
| Immunosuppressive Agents | 4 | 2025 | 673 | 0.440 |
Why?
|
| Risk Assessment | 6 | 2019 | 3727 | 0.430 |
Why?
|
| Tissue and Organ Procurement | 2 | 2023 | 246 | 0.430 |
Why?
|
| Myocardium | 6 | 2013 | 907 | 0.410 |
Why?
|
| Male | 71 | 2025 | 64952 | 0.410 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 952 | 0.410 |
Why?
|
| Anemia, Iron-Deficiency | 3 | 2021 | 141 | 0.410 |
Why?
|
| Kaplan-Meier Estimate | 10 | 2021 | 1126 | 0.410 |
Why?
|
| Female | 72 | 2025 | 70699 | 0.400 |
Why?
|
| Treatment Outcome | 27 | 2025 | 13015 | 0.390 |
Why?
|
| Humans | 94 | 2025 | 132081 | 0.370 |
Why?
|
| Cardiac Output, Low | 3 | 2007 | 62 | 0.330 |
Why?
|
| Histocompatibility Testing | 1 | 2010 | 110 | 0.320 |
Why?
|
| Extracorporeal Membrane Oxygenation | 5 | 2019 | 659 | 0.320 |
Why?
|
| Heart Failure, Systolic | 2 | 2021 | 35 | 0.320 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 3 | 2015 | 44 | 0.310 |
Why?
|
| Hospitalization | 10 | 2022 | 1897 | 0.300 |
Why?
|
| HLA Antigens | 1 | 2010 | 219 | 0.300 |
Why?
|
| Antibodies | 1 | 2010 | 366 | 0.300 |
Why?
|
| Registries | 5 | 2021 | 1591 | 0.280 |
Why?
|
| Immunocompromised Host | 2 | 2020 | 308 | 0.280 |
Why?
|
| Predictive Value of Tests | 10 | 2017 | 2312 | 0.280 |
Why?
|
| Cardiomyopathy, Restrictive | 2 | 2020 | 22 | 0.280 |
Why?
|
| Stroke Volume | 7 | 2017 | 536 | 0.280 |
Why?
|
| Proportional Hazards Models | 5 | 2019 | 1460 | 0.270 |
Why?
|
| Heart Defects, Congenital | 5 | 2022 | 1866 | 0.270 |
Why?
|
| Myocarditis | 4 | 2015 | 131 | 0.270 |
Why?
|
| Cohort Studies | 16 | 2021 | 5169 | 0.270 |
Why?
|
| Glomerular Filtration Rate | 2 | 2021 | 573 | 0.270 |
Why?
|
| Infant, Newborn | 18 | 2022 | 8540 | 0.260 |
Why?
|
| Ventricular Function, Left | 5 | 2022 | 548 | 0.260 |
Why?
|
| Organ Transplantation | 2 | 2020 | 180 | 0.250 |
Why?
|
| Renal Insufficiency | 2 | 2015 | 256 | 0.240 |
Why?
|
| Everolimus | 1 | 2025 | 50 | 0.240 |
Why?
|
| Mycophenolic Acid | 1 | 2025 | 57 | 0.240 |
Why?
|
| Hospitals, Pediatric | 5 | 2018 | 780 | 0.230 |
Why?
|
| Tacrolimus | 1 | 2025 | 104 | 0.230 |
Why?
|
| Biopsy | 6 | 2023 | 1288 | 0.220 |
Why?
|
| Arginine Vasopressin | 1 | 2004 | 28 | 0.210 |
Why?
|
| Tachycardia, Ventricular | 3 | 2016 | 211 | 0.210 |
Why?
|
| Risk Factors | 15 | 2020 | 10936 | 0.210 |
Why?
|
| Hospital Charges | 2 | 2015 | 65 | 0.210 |
Why?
|
| Heart | 5 | 2022 | 689 | 0.200 |
Why?
|
| Incidental Findings | 1 | 2024 | 131 | 0.200 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 2 | 2022 | 30 | 0.200 |
Why?
|
| Parvoviridae Infections | 3 | 2013 | 37 | 0.200 |
Why?
|
| Prosthesis Implantation | 2 | 2017 | 154 | 0.200 |
Why?
|
| Survival Rate | 6 | 2021 | 2192 | 0.200 |
Why?
|
| Echocardiography, Doppler | 3 | 2015 | 172 | 0.190 |
Why?
|
| Heart Diseases | 3 | 2013 | 511 | 0.180 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 78 | 0.180 |
Why?
|
| Educational Status | 2 | 2020 | 294 | 0.180 |
Why?
|
| Thrombosis | 2 | 2022 | 528 | 0.180 |
Why?
|
| Coronary Artery Disease | 4 | 2015 | 893 | 0.170 |
Why?
|
| Tissue Donors | 4 | 2024 | 503 | 0.170 |
Why?
|
| Probability | 2 | 2019 | 322 | 0.170 |
Why?
|
| Young Adult | 12 | 2023 | 9938 | 0.160 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2020 | 19 | 0.160 |
Why?
|
| Prognosis | 8 | 2019 | 5013 | 0.160 |
Why?
|
| Heart Valve Diseases | 1 | 2021 | 178 | 0.160 |
Why?
|
| Cardiac Catheterization | 7 | 2023 | 671 | 0.160 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2024 | 289 | 0.160 |
Why?
|
| Cardiac Rehabilitation | 1 | 2020 | 29 | 0.160 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 204 | 0.160 |
Why?
|
| Incidence | 9 | 2025 | 3370 | 0.160 |
Why?
|
| Myocardial Contraction | 2 | 2020 | 254 | 0.160 |
Why?
|
| Bilirubin | 1 | 2019 | 128 | 0.150 |
Why?
|
| Cardiac Output | 2 | 2012 | 166 | 0.150 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2019 | 107 | 0.150 |
Why?
|
| Age Factors | 8 | 2021 | 2921 | 0.150 |
Why?
|
| Overweight | 1 | 2021 | 383 | 0.150 |
Why?
|
| Perioperative Care | 1 | 2020 | 212 | 0.140 |
Why?
|
| Exercise Therapy | 1 | 2020 | 183 | 0.140 |
Why?
|
| Allografts | 2 | 2017 | 196 | 0.140 |
Why?
|
| Pulmonary Artery | 3 | 2015 | 463 | 0.140 |
Why?
|
| Tracheostomy | 1 | 2020 | 203 | 0.140 |
Why?
|
| Troponin T | 1 | 2020 | 295 | 0.140 |
Why?
|
| Coronary Vessels | 3 | 2024 | 549 | 0.140 |
Why?
|
| Transplant Recipients | 1 | 2019 | 225 | 0.140 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2016 | 113 | 0.140 |
Why?
|
| Shock, Cardiogenic | 2 | 2018 | 213 | 0.130 |
Why?
|
| Echocardiography | 4 | 2018 | 1126 | 0.130 |
Why?
|
| Multivariate Analysis | 7 | 2019 | 1440 | 0.130 |
Why?
|
| Surgical Fixation Devices | 1 | 2017 | 3 | 0.130 |
Why?
|
| Pectus Carinatum | 1 | 2017 | 5 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 3358 | 0.130 |
Why?
|
| Titanium | 1 | 2017 | 26 | 0.130 |
Why?
|
| Anthracyclines | 1 | 2017 | 44 | 0.130 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2020 | 271 | 0.130 |
Why?
|
| Natriuretic Agents | 2 | 2007 | 28 | 0.130 |
Why?
|
| Wound Closure Techniques | 1 | 2017 | 27 | 0.130 |
Why?
|
| Logistic Models | 1 | 2021 | 1836 | 0.130 |
Why?
|
| Nitric Oxide | 1 | 2019 | 470 | 0.130 |
Why?
|
| Heart Ventricles | 2 | 2018 | 785 | 0.130 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2017 | 51 | 0.130 |
Why?
|
| Parvovirus B19, Human | 3 | 2013 | 31 | 0.130 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 503 | 0.120 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2017 | 42 | 0.120 |
Why?
|
| Clostridium Infections | 1 | 2019 | 248 | 0.120 |
Why?
|
| DNA, Viral | 3 | 2013 | 492 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2016 | 33 | 0.120 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2017 | 128 | 0.120 |
Why?
|
| Oxygen | 1 | 2019 | 569 | 0.120 |
Why?
|
| Adult | 16 | 2023 | 31558 | 0.120 |
Why?
|
| Gadolinium DTPA | 1 | 2016 | 49 | 0.120 |
Why?
|
| Heart Arrest | 3 | 2017 | 373 | 0.120 |
Why?
|
| Hospital Mortality | 3 | 2020 | 1078 | 0.120 |
Why?
|
| Atrial Function, Right | 1 | 2015 | 9 | 0.120 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2015 | 51 | 0.120 |
Why?
|
| Hyponatremia | 1 | 2016 | 74 | 0.120 |
Why?
|
| Ventricular Pressure | 1 | 2015 | 38 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1204 | 0.120 |
Why?
|
| Device Removal | 1 | 2017 | 225 | 0.110 |
Why?
|
| Ventricular Dysfunction | 1 | 2015 | 25 | 0.110 |
Why?
|
| Follow-Up Studies | 10 | 2018 | 5407 | 0.110 |
Why?
|
| Liver Transplantation | 2 | 2021 | 1102 | 0.110 |
Why?
|
| Sirolimus | 1 | 2016 | 241 | 0.110 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2016 | 175 | 0.110 |
Why?
|
| Anemia | 1 | 2018 | 350 | 0.110 |
Why?
|
| Mortality | 1 | 2016 | 260 | 0.110 |
Why?
|
| Thermodilution | 2 | 2012 | 13 | 0.110 |
Why?
|
| Renal Dialysis | 1 | 2021 | 947 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 2087 | 0.100 |
Why?
|
| Endocardium | 1 | 2013 | 54 | 0.100 |
Why?
|
| Aorta | 1 | 2017 | 552 | 0.100 |
Why?
|
| Waiting Lists | 1 | 2014 | 237 | 0.100 |
Why?
|
| Severity of Illness Index | 5 | 2020 | 3086 | 0.100 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 990 | 0.100 |
Why?
|
| Health Care Costs | 1 | 2015 | 407 | 0.090 |
Why?
|
| United States | 8 | 2021 | 11652 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1829 | 0.090 |
Why?
|
| Ultrasonography | 3 | 2012 | 988 | 0.090 |
Why?
|
| Dextrocardia | 1 | 2012 | 9 | 0.090 |
Why?
|
| Hemodynamics | 4 | 2022 | 861 | 0.090 |
Why?
|
| Pseudomonas Infections | 1 | 2013 | 116 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2022 | 479 | 0.090 |
Why?
|
| Candidiasis | 1 | 2013 | 137 | 0.090 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2011 | 27 | 0.090 |
Why?
|
| Sarcomeres | 2 | 2022 | 33 | 0.090 |
Why?
|
| Heart, Artificial | 1 | 2012 | 69 | 0.090 |
Why?
|
| Sensitivity and Specificity | 4 | 2012 | 2138 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 926 | 0.090 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 554 | 0.080 |
Why?
|
| Tachycardia | 2 | 2013 | 68 | 0.080 |
Why?
|
| Transposition of Great Vessels | 1 | 2012 | 135 | 0.080 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2013 | 292 | 0.080 |
Why?
|
| Diastole | 3 | 2020 | 181 | 0.080 |
Why?
|
| Biomarkers | 3 | 2009 | 3404 | 0.080 |
Why?
|
| Time Factors | 5 | 2018 | 6443 | 0.080 |
Why?
|
| Electrocardiography | 4 | 2012 | 996 | 0.080 |
Why?
|
| Genome, Viral | 1 | 2010 | 179 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 377 | 0.080 |
Why?
|
| Systole | 2 | 2006 | 205 | 0.070 |
Why?
|
| Isoantibodies | 1 | 2008 | 58 | 0.070 |
Why?
|
| Pacemaker, Artificial | 2 | 2017 | 188 | 0.070 |
Why?
|
| Body Mass Index | 2 | 2021 | 1700 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1831 | 0.070 |
Why?
|
| Immunoassay | 1 | 2008 | 135 | 0.070 |
Why?
|
| Virus Diseases | 1 | 2011 | 289 | 0.070 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 569 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 275 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 234 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2010 | 881 | 0.070 |
Why?
|
| Databases, Factual | 3 | 2017 | 1230 | 0.070 |
Why?
|
| Length of Stay | 3 | 2019 | 1380 | 0.070 |
Why?
|
| Cachexia | 1 | 2007 | 54 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2019 | 3414 | 0.070 |
Why?
|
| Transplantation Immunology | 1 | 2007 | 45 | 0.070 |
Why?
|
| Pulse | 1 | 2006 | 27 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2008 | 436 | 0.060 |
Why?
|
| Ticlopidine | 1 | 2006 | 29 | 0.060 |
Why?
|
| Prospective Studies | 7 | 2017 | 6557 | 0.060 |
Why?
|
| Infusions, Parenteral | 1 | 2006 | 79 | 0.060 |
Why?
|
| Milrinone | 1 | 2006 | 30 | 0.060 |
Why?
|
| Long QT Syndrome | 1 | 2006 | 85 | 0.060 |
Why?
|
| Glycogen Storage Disease Type IIb | 1 | 2005 | 6 | 0.060 |
Why?
|
| Leukopenia | 1 | 2005 | 47 | 0.060 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2007 | 185 | 0.060 |
Why?
|
| Tertiary Care Centers | 2 | 2019 | 258 | 0.060 |
Why?
|
| Reference Values | 1 | 2006 | 703 | 0.060 |
Why?
|
| Codon, Nonsense | 1 | 2005 | 144 | 0.060 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 136 | 0.060 |
Why?
|
| Dopamine | 1 | 2006 | 253 | 0.060 |
Why?
|
| Fibrinolytic Agents | 1 | 2006 | 207 | 0.060 |
Why?
|
| Leukocytes | 1 | 2005 | 209 | 0.060 |
Why?
|
| Cause of Death | 1 | 2007 | 507 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2005 | 83 | 0.050 |
Why?
|
| Outpatients | 1 | 2006 | 275 | 0.050 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2025 | 225 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2008 | 490 | 0.050 |
Why?
|
| Pulmonary Circulation | 1 | 2004 | 117 | 0.050 |
Why?
|
| Cytomegalovirus Infections | 1 | 2025 | 224 | 0.050 |
Why?
|
| Disease Progression | 4 | 2016 | 2232 | 0.050 |
Why?
|
| Prevalence | 3 | 2018 | 2662 | 0.050 |
Why?
|
| Obesity | 2 | 2021 | 2398 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1175 | 0.050 |
Why?
|
| Comorbidity | 3 | 2015 | 1610 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2005 | 257 | 0.050 |
Why?
|
| Anemia, Sickle Cell | 1 | 2006 | 330 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2006 | 412 | 0.050 |
Why?
|
| Patient Selection | 1 | 2006 | 730 | 0.050 |
Why?
|
| Chlorides | 1 | 2022 | 103 | 0.050 |
Why?
|
| Hirudins | 1 | 2022 | 36 | 0.050 |
Why?
|
| Antithrombins | 1 | 2022 | 51 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2025 | 1177 | 0.050 |
Why?
|
| Mass Screening | 1 | 2008 | 830 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2022 | 49 | 0.050 |
Why?
|
| Cytokines | 1 | 2008 | 1365 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2025 | 1670 | 0.050 |
Why?
|
| Transferrin | 1 | 2021 | 47 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 312 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2017 | 670 | 0.050 |
Why?
|
| Diuretics | 1 | 2022 | 160 | 0.050 |
Why?
|
| Critical Care | 1 | 2007 | 686 | 0.040 |
Why?
|
| Thinness | 1 | 2021 | 74 | 0.040 |
Why?
|
| Hemolysis | 1 | 2021 | 107 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 296 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 217 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2016 | 64 | 0.040 |
Why?
|
| Heparin | 1 | 2022 | 212 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2021 | 274 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2022 | 282 | 0.040 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 2020 | 10 | 0.040 |
Why?
|
| Recurrence | 2 | 2019 | 1452 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2017 | 462 | 0.040 |
Why?
|
| Texas | 3 | 2016 | 3632 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2024 | 540 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2020 | 168 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 404 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 1350 | 0.040 |
Why?
|
| Iron | 1 | 2021 | 302 | 0.040 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 59 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 517 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2021 | 485 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 800 | 0.040 |
Why?
|
| Fontan Procedure | 1 | 2020 | 190 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2022 | 609 | 0.030 |
Why?
|
| Exercise Test | 2 | 2011 | 256 | 0.030 |
Why?
|
| Wechsler Scales | 1 | 2016 | 20 | 0.030 |
Why?
|
| Cardiotoxicity | 1 | 2017 | 40 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2025 | 846 | 0.030 |
Why?
|
| Intelligence Tests | 1 | 2016 | 63 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1161 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 229 | 0.030 |
Why?
|
| Stroke | 2 | 2015 | 1082 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2017 | 260 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 215 | 0.030 |
Why?
|
| Heart Septum | 1 | 2015 | 55 | 0.030 |
Why?
|
| United Kingdom | 1 | 2015 | 234 | 0.030 |
Why?
|
| Vascular Patency | 1 | 2015 | 188 | 0.030 |
Why?
|
| Child Behavior | 1 | 2016 | 236 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2009 | 1571 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2015 | 127 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 2015 | 195 | 0.030 |
Why?
|
| Child Development | 1 | 2016 | 271 | 0.030 |
Why?
|
| Stents | 1 | 2020 | 874 | 0.030 |
Why?
|
| Syndrome | 2 | 2008 | 1174 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2003 | 2491 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 711 | 0.030 |
Why?
|
| Mothers | 1 | 2016 | 372 | 0.030 |
Why?
|
| Pseudomonas | 1 | 2013 | 12 | 0.030 |
Why?
|
| Algorithms | 2 | 2011 | 1725 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 1096 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 2015 | 247 | 0.020 |
Why?
|
| Atrial Flutter | 1 | 2013 | 35 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2016 | 1255 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 551 | 0.020 |
Why?
|
| Staphylococcus | 1 | 2013 | 68 | 0.020 |
Why?
|
| Mitral Valve | 1 | 2015 | 269 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2015 | 487 | 0.020 |
Why?
|
| Candida | 1 | 2013 | 84 | 0.020 |
Why?
|
| Contrast Media | 1 | 2016 | 507 | 0.020 |
Why?
|
| Infant Mortality | 1 | 2013 | 178 | 0.020 |
Why?
|
| Sternotomy | 1 | 2012 | 43 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2019 | 804 | 0.020 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2012 | 86 | 0.020 |
Why?
|
| Cognition | 1 | 2016 | 811 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 796 | 0.020 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2012 | 79 | 0.020 |
Why?
|
| Coxsackievirus Infections | 1 | 2010 | 10 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 463 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2013 | 673 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2012 | 157 | 0.020 |
Why?
|
| Adenoviridae Infections | 1 | 2010 | 69 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 2703 | 0.020 |
Why?
|
| Enterovirus | 1 | 2010 | 52 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2012 | 373 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2013 | 568 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 995 | 0.020 |
Why?
|
| Medical Records | 1 | 2009 | 189 | 0.020 |
Why?
|
| Patient Safety | 1 | 2013 | 438 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 3015 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 1161 | 0.020 |
Why?
|
| Assisted Circulation | 1 | 2007 | 37 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2008 | 68 | 0.020 |
Why?
|
| Diuresis | 1 | 2007 | 46 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2008 | 138 | 0.020 |
Why?
|
| Aldosterone | 1 | 2007 | 65 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2007 | 43 | 0.020 |
Why?
|
| Hypotension | 1 | 2009 | 185 | 0.020 |
Why?
|
| Renin | 1 | 2007 | 95 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2010 | 596 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 163 | 0.020 |
Why?
|
| Sepsis | 1 | 2012 | 516 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2007 | 166 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2850 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2006 | 55 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1555 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2007 | 258 | 0.020 |
Why?
|
| Defibrillators, Implantable | 1 | 2009 | 204 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2010 | 685 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 437 | 0.020 |
Why?
|
| Equipment Failure | 1 | 2006 | 136 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2005 | 10 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2008 | 435 | 0.020 |
Why?
|
| Papillary Muscles | 1 | 2005 | 17 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2008 | 539 | 0.010 |
Why?
|
| Creatinine | 1 | 2007 | 413 | 0.010 |
Why?
|
| Inflammation | 1 | 2013 | 1522 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 666 | 0.010 |
Why?
|
| Drug Overdose | 1 | 2006 | 73 | 0.010 |
Why?
|
| Warfarin | 1 | 2006 | 128 | 0.010 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2005 | 73 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 424 | 0.010 |
Why?
|
| ROC Curve | 1 | 2006 | 600 | 0.010 |
Why?
|
| Patient Admission | 1 | 2006 | 186 | 0.010 |
Why?
|
| Aspirin | 1 | 2006 | 220 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 18502 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 2005 | 117 | 0.010 |
Why?
|
| Heart Rate | 1 | 2007 | 584 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 547 | 0.010 |
Why?
|
| Medical Errors | 1 | 2006 | 161 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 2003 | 69 | 0.010 |
Why?
|
| Acyltransferases | 1 | 2003 | 45 | 0.010 |
Why?
|
| Mitochondrial Myopathies | 1 | 2003 | 28 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2005 | 750 | 0.010 |
Why?
|
| Bradycardia | 1 | 2004 | 60 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2163 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 242 | 0.010 |
Why?
|
| Exercise Tolerance | 1 | 2004 | 87 | 0.010 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2003 | 115 | 0.010 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2004 | 88 | 0.010 |
Why?
|
| Exercise | 1 | 2009 | 860 | 0.010 |
Why?
|
| Chest Pain | 1 | 2004 | 128 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 2004 | 186 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2004 | 304 | 0.010 |
Why?
|
| Abdominal Pain | 1 | 2005 | 314 | 0.010 |
Why?
|
| Resuscitation | 1 | 2005 | 268 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 2680 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 1338 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 34845 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2005 | 1037 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2005 | 2510 | 0.010 |
Why?
|
| Proteins | 1 | 2003 | 1038 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2006 | 1163 | 0.010 |
Why?
|